Sarepta Therapeutics (SRPT) Fell Despite Reporting Good Results
Carillon Tower Advisers, an investment management company, released its “Carillon Eagle Mid Cap Growth Fund” second-quarter 2025 investor letter. A…
Tag: SRPT
Was Jim Cramer Right About Sarepta Therapeutics Inc. (SRPT)?
We recently published a list of Was Jim Cramer Right About These 11 Stocks? In this article, we are going…